Cargando…

Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development

Information generated from economic evaluation is increasingly being used to inform health resource allocation decisions globally, including in low- and middle- income countries. However, a crucial consideration for users of the information at a policy level, e.g. funding agencies, is whether the st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santatiwongchai, Benjarin, Chantarastapornchit, Varit, Wilkinson, Thomas, Thiboonboon, Kittiphong, Rattanavipapong, Waranya, Walker, Damian G, Chalkidou, Kalipso, Teerawattananon, Yot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Collection Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423853/ https://www.ncbi.nlm.nih.gov/pubmed/25950443 http://dx.doi.org/10.1371/journal.pone.0123853

Ejemplares similares

Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
por: Culyer, Anthony, et al.
Publicado: (2018)

Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low- and middle-income countries
por: Luz, Alia, et al.
Publicado: (2018)

Historical development of the htasialink network and its key determinants of success
por: Teerawattananon, Yot, et al.
Publicado: (2018)

An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities
por: Thiboonboon, Kittiphong, et al.
Publicado: (2018)

The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries’ Health Economics Practitioners: A Commentary
por: Adeagbo, Chiaki Urai, et al.
Publicado: (2018)

Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand
por: Bussabawalai, Thanaporn, et al.
Publicado: (2019)

Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
por: Rattanavipapong, Waranya, et al.
Publicado: (2018)

Using health technology assessment to set priority, inform target product profiles, and design clinical study for health innovation
por: Wang, Yi, et al.
Publicado: (2021)

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE
por: Tantivess, Sripen, et al.
Publicado: (2017)

Vaccination program in a resource-limited setting: A case study in the Philippines
por: Chootipongchaivat, Sarocha, et al.
Publicado: (2016)

Retrospective secondary data analysis to identify high-cost users in inpatient department of hospitals in Thailand, a middle-income country with universal healthcare coverage
por: Rattanavipapong, Waranya, et al.
Publicado: (2021)

Economic evaluation of endovascular treatment for acute ischaemic stroke in Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2022)

An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand
por: Thiboonboon, Kittiphong, et al.
Publicado: (2015)

Designing the Free Drugs List in Nepal: A Balancing Act Between Technical Strengths and Policy Processes
por: Singh, Devika, et al.
Publicado: (2017)

Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2023)

Adherence to the iDSI reference case among published cost-per-DALY averted studies
por: Emerson, Joanna, et al.
Publicado: (2019)

Institutionalizing Evidence-Informed Priority Setting for Universal Health Coverage: Lessons From Indonesia
por: Sharma, Manushi, et al.
Publicado: (2020)

A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines
por: Guerrero, Anna Melissa, et al.
Publicado: (2015)

Charging for the use of survey instruments on population health: the case of quality-adjusted life years
por: Teerawattananon, Yot, et al.
Publicado: (2020)

How Should Global Fund Use Value-for-Money Information to Sustain its Investments in Graduating Countries?
por: Kanpirom, Kitti, et al.
Publicado: (2017)

An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations
por: Turner, Hugo C., et al.
Publicado: (2021)

Foreword: Health Economic Evaluations in Low‐ and Middle‐income Countries: Methodological Issues and Challenges for Priority Setting
por: Pitt, Catherine, et al.
Publicado: (2016)

Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections
por: Kulpeng, Wantanee, et al.
Publicado: (2013)

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice: Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2018)

Analyses of the return on investment of public health interventions: a scoping review and recommendations for future studies
por: Turner, Hugo C, et al.
Publicado: (2023)

Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

What is the value of explicit priority setting for health interventions? A simulation study
por: Barlow, Euan, et al.
Publicado: (2022)

Tackling the 3 Big Challenges Confronting Health Technology Assessment Development in Asia: A Commentary
por: Teerawattananon, Yot, et al.
Publicado: (2020)

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2020)

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making
por: Teerawattananon, Yot, et al.
Publicado: (2021)

Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact
por: Millar, Robyn, et al.
Publicado: (2021)

Prevention of non-communicable disease: best buys, wasted buys, and contestable buys
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2020)

Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
por: Culyer, Anthony J., et al.
Publicado: (2019)

Economic costs of alcohol use in Sri Lanka
por: Ranaweera, Sajeeva, et al.
Publicado: (2018)

Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India
por: Dabak, Saudamini Vishwanath, et al.
Publicado: (2018)

Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings
por: Marsh, Kevin, et al.
Publicado: (2018)

Evaluating Payments for Environmental Services: Methodological Challenges
por: Le Velly, Gwenolé, et al.
Publicado: (2016)

Dispelling the myths of providing dialysis in low- and middle-income countries
por: Teerawattananon, Yot, et al.
Publicado: (2020)

Priority-setting for achieving universal health coverage
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand
por: Teerawattananon, Yot, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_jqu3gs4ttru3tlpdbqovhiplbq